Colgate-Palmolive Co (NYSE:CL)

$ 106.34 0.21 (0.2%) Market Cap: 86.89 Bil Enterprise Value: 94.28 Bil PE Ratio: 30.82 PB Ratio: 708.93 GF Score: 82/100

Q2 2024 Colgate-Palmolive Co Earnings Call Transcript

Jul 26, 2024 / 12:30PM GMT

Release Date Price: $99.39 (+3.01%)

Transcript 10-Q8-K

Key Points

Positve

Colgate-Palmolive Co (CL) reported strong Q2 results with balanced organic sales growth across all six divisions and four categories.
The company achieved mid-single-digit volume growth, including notable performance from Hill's and Holly and Hazel brands.
Gross margins are expanding, driving incremental gross profit to fund brand investments and capabilities while delivering bottom-line growth.
Colgate-Palmolive Co (CL) is leveraging data and analytics tools, including AI, to optimize the return on increased marketing spending.
The company is well-positioned to drive consistent, balanced top-line growth and top-tier total shareholder return (TSR).

Negative

The company faces a more promotional environment in North America, which could impact pricing and margins.
There are concerns about the sustainability of volume growth given the competitive landscape and potential shifts in consumer behavior.
Colgate-Palmolive Co (CL) anticipates some raw material inflation and transactional FX impacts in the second half of the year.
The Latin American market, while strong, showed some signs of slowing in Mexico, which could affect overall regional performance.
Foreign exchange fluctuations, particularly in Latin American currencies, pose a risk to financial performance.

Operator

Good morning. Welcome to today's Colgate-Palmolive second quarter 2024 earnings conference call. This call is being recorded and is being simulcast live, www.colgate-palmolive.com.

Now for opening remarks, I'd like to turn this call over to Chief Investor Relations Officer and Executive Vice Presidents and a John for Shay.

John Faucher

Colgate-Palmolive Company - Chief IR Officer and Executive VP of M&A

Thanks, Rob. Good morning and welcome to our second quarter 2024 earnings release conference call. This is John Faucher. Today's conference call will include forward-looking statements and actual results could differ materially from these statements. Please refer to the second quarter 2024 earnings press release and related prepared materials and our most recent filings with the SEC, including our 2023 Annual Report on Form 10-K and subsequent SEC filings all available on Colgate's website for a discussion of the factors that could cause actual results to differ materially

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.